期刊文献+

台湾地区创新药医保支付方式经验及启示研究 被引量:2

Study on the experience and enlightenment of medical insurance payment of innovative drugs in Taiwan China
原文传递
导出
摘要 为让患者更及时地使用创新药,降低健康保险财务风险,发挥健康保险资源最高效能,台湾地区采取了以疗效、财务协议为基础的、多元的创新药医保支付方式。本文将通过政策检索梳理分析台湾地区创新药分类、健康保险给付流程与支付方式的具体经验,以期为我国大陆地区创新药医保支付方式探索提供借鉴。 In order to enable patients to use innovative drugs more timely,reduce the financial risk of health insurance,and give full play to the highest efficiency of health insurance resources,Taiwan China has adopted a diversified payment method of innovative drugs based on curative effect and financial agreement.This paper combed and analyzed the specific experience of innovative medicine classification,health insurance payment process and payment method in Taiwan China through policy retrieval,in order to provide reference for the exploration of innovative medicine medical insurance payment method in China's Mainland.
作者 王美凤 王海银 丛鹂萱 谢春艳 刘昕 金春林 WANG Meifeng;WANG Haiyin;CONG Lixuan;XIE Chunyan;LIU Xin;JIN Chunlin(Shanghai Health Development Research Center,Shanghai 200040,China)
出处 《世界临床药物》 2021年第3期223-228,共6页 World Clinical Drug
关键词 台湾地区 创新药 医保支付 疗效协议 财务协议 Taiwan China innovative drug medical insurance payment therapeutic effect agreement financial agreement
  • 相关文献

参考文献5

二级参考文献37

共引文献29

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部